Oxford-Harrington Rare Disease Scholar Award

The award combines funding and expert therapeutics development support to help researchers in the UK, US, or Canada to accelerate preclinical projects towards treatments for patients. The Oxford-Harrington Rare Disease Scholar Award accelerates breakthrough academic discoveries into new treatments for rare diseases with an emphasis on neurological disorders, developmental and metabolic disorders, and rare cancers. Other rare genetic indications with high unmet need are also eligible for the award.

Funding Information

• Guaranteed grant award of £100,000 (£50,000 for year one and £50,000 for year two) for UK-based awardees or USD$100,000 ($50,000 for year one and $50,000 for year two) for US- and Canada-based awardees
• One year of therapeutics development support and project management, with potential to renew for a second year based on milestones met
• Access to core facilities and infrastructure including oligonucleotide synthesis and screening, small molecule and protein platforms and cell and gene therapy facilities
• Opportunity to compete for acceleration funds up to £250,000 (UK) or USD$300,000 (US and CA)
• Opportunity to qualify for investment funds up to USD$1,000,000 according to project requirements
• Invitation to present at a Harrington Discovery Institute or Oxford-Harrington Rare Disease Centre Scientific Symposium

Eligibility Criteria

• MD or PhD (or equivalent) researchers in the UK, US, and Canada operating their own independent lab
• Faculty position at an accredited academic medical centre, university or research institution in the UK, US or Canada, and conduct the majority of their research at that institution
• A project must have a single Principal Investigator (PI), who is responsible for project oversight and financial management. The PI may engage collaborators, core labs or commercial Contract Research Organisations (CROs) to execute any portion of the project.

For more information, visit Oxford-Harrington Rare Disease Centre.